alexa Varun khurana | Insys Therapeutics Inc.
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Varun khurana

Varun khurana Varun Khurana
Formulation Scientist
INSYS Therapeutics.INC
Chandler
AZ, USA
Biography

Dr. Varun Khurana obtained his Bachelors in Pharmacy from Guru Gobind Singh Indraprastha University, Delhi,, India. Dr. Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO, USA. Currently, he is working as Formulations Scientist at Insys Therapeutics, Inc., USA, a specialty pharmaceutical company that develops and commercializes innovative supportive care products. Dr. Khurana’s research experience encompasses both industry and academia. Dr. Khurana worked on National Institutes of Health (NIH) funded research projects. Dr. Khurana’s research was focused on understanding the role of drug transporters (influx as well as efflux) in disposition of various anti-cancer drugs. He not only studied the alteration of drug pharmacokinetics via drug transporters in liver but also how the modulation affects brain as well plasma pharmacokinetics of anti-cancer drugs. Furthermore, his research work was focused on ocular drug delivery through nanoparticles. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences. Dr. Khurana’s current research at Insys Therapeutics is focused on development of oral solutions and sublingual sprays for new product development.

Research Interest

Novel Drug Delivery Systems, Solubility and Bioavailability Enhancement, Targeted Drug Delivery, Cancer Therapy, Targeted Delivery, Gene Therapy, Nanotechnology, Novel Drug Delivery Systems, Formulation Development (Oral solids, Liquid and Parenterals), Controlled or Modified Release.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Tyrosine Kinase: Targeted Anti-Cancer Therapy
Varun Khurana* and Ravi D Vaishya
Editorial: Clin Pharmacol Biopharm 2015, 4:E119
DOI: 10.4172/2167-065X.1000e119
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords